Botulinum toxin therapy for isolated first dorsal interosseous muscle pain and hypertrophy: A case report

Abstract

Key Clinical Message Botulinum toxin (BTX) injection can be an effective treatment for persistent pain and functional impairment associated with hypertrophy of the first dorsal interosseous muscle. It offers a non‐surgical and minimally invasive alternative for those who have failed conservative treatment, showcasing the therapeutic promise of BTX for addressing similar musculoskeletal conditions.

Keywords

• botulinum toxin type A
• first dorsal interosseous muscle
• muscle hypertrophy
• pain management